WADA Drops Lawsuit Against USADA Amid Controversy Over Chinese Swimmers' Doping Tests

The World Anti-Doping Agency (WADA) has withdrawn its lawsuit against the U.S. Anti-Doping Agency (USADA) concerning 23 Chinese swimmers who failed drug tests before the 2021 Tokyo Olympics. WADA cited a desire to focus on enhancing the global anti-doping system, following an investigation that found no favoritism toward China.

The World Anti-Doping Agency (WADA) announced on Friday it has decided to drop its lawsuit against the U.S. Anti-Doping Agency (USADA). This legal battle stemmed from allegations surrounding 23 Chinese swimmers who tested positive for banned substances before the 2021 Tokyo Olympics.

This dispute saw a flurry of accusations traded between WADA and USADA, with an investigation initiated by Swiss prosecutor Eric Cottier. The findings revealed that WADA had not demonstrated any 'favoritism or complacency' towards China. Meanwhile, Chinese authorities asserted that the swimmers' positive tests for trimetazidine were caused by contamination from spice containers in a hotel kitchen.

In response, USADA called for provisional suspensions and criticized WADA for lacking transparency. WADA proceeded with a lawsuit against USADA and its CEO, Travis Tygart, to defend its integrity. Ultimately, WADA retracted the lawsuit, citing an interest in strengthening the global anti-doping system. USADA's Tygart described the lawsuit as 'unauthorized and baseless,' advocating for robust watchdog measures to protect athletes' rights.